Intravenous Ciprofloxacin Therapy in Respiratory Infections

Sarah Shahabuddin, Faroque Ahmad Khan

Abstract


DOI: http://dx.doi.org/10.5915/24-1-15458

Of the quinolone class of antimicrobials, only intravenous (IV) ciprofloxacin is currently available for treatment of various bacterial infections. Pathogens causing pneumonia in otherwise healthy adult patients may differ from those found in elderly patients, nursing home residents, alcoholics, and in individuals with debilitating diseases. Nosocomial pneumonias typically involve Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, and Escherichia coli. Aspiration pneumonia in the community most often involves anaerobes, but in the hospital S. aureus and Gram-negative organisms are commonly found. Based on these clinical and microbiological issues, a comparative evaluation of sequential IV and oral (PO) ciprofloxacin versus other antibiotics were reviewed and the results are summarized in this article. The focus is on the role of sequential intravenous/oral ciprofloxacin in the treatment of lower respiratory tract injection.

Presented at the lMA 24th Annual Convention Long Island, New York, July 1991


Keywords


Fluoroquinolones; ciprofloxacin; infection; respiratory tract; sequential therapy

Full Text:

PDF


DOI: https://doi.org/10.5915/24-1-15458




Islamic Medical Association of North America (IMANA) | JIMA and IMANA on Twitter

 

Creative Commons License
This work by Work's author(s) is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.